Date Filed | Type | Description |
05/12/2023 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Exercised 100,000 options to buy
@ $0.79, valued at
$79k
|
|
12/29/2022 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Granted 146,000 options to buy
@ $18.59, valued at
$2.7M
Granted 42,000 restricted stock units
@ $0 |
|
12/08/2022 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Exercised 20,000 restricted stock units
@ $0 |
|
11/23/2022 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Sold 80,000 shares
@ $15.276, valued at
$1.2M
Sold 20,000 shares
@ $17.337, valued at
$346.7k
|
|
09/15/2022 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Sold 25,000 shares
@ $17.007, valued at
$425.2k
Sold 7,933 shares
@ $17.111, valued at
$135.7k
Sold 75,000 shares
@ $16.846, valued at
$1.3M
|
|
08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/16/2022 |
4
| Miller Steve (Chief Oper./Scientific Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Granted 41,000 restricted stock units
@ $0 |
|
12/30/2021 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Granted 185,000 options to buy
@ $7.07, valued at
$1.3M
|
|
12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/28/2020 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Exercised 20,000 shares
@ $0 Granted 20,000 restricted stock units
@ $0 |
|
12/04/2019 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Granted 180,000 options to buy
@ $4.64, valued at
$835.2k
Granted 60,000 restricted stock units
@ $0 |
|
12/21/2018 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Granted 75,000 options to buy
@ $2.24, valued at
$168k
|
|
01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/07/2017 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Exercised 200,000 options to buy
@ $0.47, valued at
$94k
|
|
01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/12/2016 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Bought 7,933 shares
@ $1.8, valued at
$14.3k
|
|
01/04/2016 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Granted 50,000 options to buy
@ $2.53, valued at
$126.5k
|
|
08/27/2015 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Exercised 60,000 options to buy
@ $1.09, valued at
$65.4k
|
|
10/03/2014 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.
Txns:
| Exercised 175,000 options to buy
@ $0.9, valued at
$157.5k
|
|
09/02/2014 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.
Txns:
| Granted 61,666 options to buy
@ $3.12, valued at
$192.4k
Granted 61,667 options to buy
@ $3.12, valued at
$192.4k
|
|
06/04/2014 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.
Txns:
| Bought 100,000 shares
@ $2.1699, valued at
$217k
|
|
12/14/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/05/2012 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.
Txns:
| Bought 12,300 shares
@ $0.546, valued at
$6.7k
Bought 27,700 shares
@ $0.55, valued at
$15.2k
|
|
12/19/2011 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.
Txns:
| Granted 30,000 options to buy
@ $1.07, valued at
$32.1k
|
|
11/09/2010 |
4
| Miller Steve (VP Development & Management) has filed a Form 4 on Catalyst Pharmaceutical Partners, Inc.
Txns:
| Granted 20,000 options to buy
@ $1.09, valued at
$21.8k
|
|
10/22/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |